46
Growth Score
pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Cardiora is a biopharmaceutical company that is focused on developing new treatments for patients with end stage heart failure.
About the Company
Cardiora is a clinical stage biopharmaceutical company that was established in 2015. Cardiora is focussed on developing new treatments for patients with end stage heart failure, which is associated with high mortality rates, recurrent hospital admissions and poor quality of life.
Cardiora’s lead program is currently in Phase Ib trials, and IND
enabling trials are currently being completed. Cardiora intends to enter Phase II trials in 2017.
